Avalon Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $4.53M | Buy |
|
|||||
|
2023
Q1 | $4.12M | Sell |
|
|||||
|
2022
Q4 | $4.58M | Buy |
|
|||||
|
2022
Q3 | $4.37M | Sell |
|
|||||
|
2022
Q2 | $4.17M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $5.54M | Buy |
|
|||||
|
2018
Q2 | $1.96M | Buy |
|
|||||
|
2018
Q1 | $1.62M | Sell |
|
|||||
|
2017
Q4 | $3.07M | Sell |
|
|||||
|
2017
Q3 | $4.29M | Buy |
|
|||||
|
2017
Q2 | $2.98M | Buy |
|
|||||
|
2017
Q1 | $1.76M | Buy |
|
|||||
|
2016
Q4 | $261K | Sell |
|
|||||
|
2016
Q3 | $2.05M | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $1.24M | Sell |
|
|||||
|
2015
Q1 | $2.38M | Sell |
|
|||||
|
2014
Q4 | $3.94M | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $392K | Buy |
|